kalcipos-d forte 500 mg/800 sv apvalkotās tabletes
meda ab, sweden - kalcija, colecalciferolum - apvalkotās tabletes - 500 mg/800 sv
calcigran forte flex 500 mg/400 sv apvalkotās tabletes
orifarm healthcare a/s, denmark - kalcija, colecalciferolum - apvalkotā tablete - 500 mg/400 sv
alendronic acid/colecalciferol sandoz 70 mg/5600 sv tabletes
sandoz d.d., slovenia - skābes alendronicum, colecalciferolum - tablete - 70 mg/5600 sv
colecalciferol krka 7000 sv tabletes
krka, d.d., novo mesto, slovenia - holekalciferols - tablete - 7000 sv
rhinallergy tabletes
boiron, france - ambrosia artemisiaefolia, euphrasia officinalis, histaminum muriaticum, šenokaulons (schoenocaulon officinale, solidago virgaurea, Ķiploku un sīpolu - tablete
nexmezol 40 mg zarnās šķīstošās tabletes
sandoz d.d., slovenia - esomeprazols - zarnās šķīstošā tablete - 40 mg
nexmezol 20 mg zarnās šķīstošās tabletes
sandoz d.d., slovenia - esomeprazols - zarnās šķīstošā tablete - 20 mg
nimenrix
pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningīts, meningokoku - vakcīnas - nimenrix ir indicēts 6 nedēļu vecuma indivīdu aktīvai imunizācijai pret inesīvās meningokoku slimībām, ko izraisa neisseria meningitidis grupas a, c, w-135 un y.
menquadfi
sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningīts, meningokoku - vakcīnas - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.
typhim vi šķīdums injekcijām
sanofi pasteur europe, france - vēdertīfa polisaharīda vakcīna - Šķīdums injekcijām pilnšļircē